arginine vasopressin has been researched along with Arterial Obstructive Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbara, F; Dünser, MW; Hasibeder, WR; Knotzer, H; Mayr, AJ; Pajk, W; Tür, A; Ulmer, H | 1 |
| Nakanishi, T; Nanbu, A; Nishimura, M; Sakamoto, M; Takahashi, H; Yoshimura, M | 1 |
| Matsuo, A; Shinoda, M; Toide, K | 1 |
3 other study(ies) available for arginine vasopressin and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Arginine Vasopressin; Arterial Occlusive Diseases; Austria; Body Mass Index; Drug Resistance; Female; Hospitals, University; Humans; Incidence; Infusions, Intravenous; Ischemia; Logistic Models; Male; Middle Aged; Multiple Organ Failure; Norepinephrine; Retrospective Studies; Risk Factors; Shock; Skin; Vasoconstrictor Agents | 2003 |
Cerebral adenosine triphosphate-sensitive K+ channels may be impaired during acute cerebral ischemia in spontaneously hypertensive rats.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Antidiuretic Hormone Receptor Antagonists; Antihypertensive Agents; Arginine Vasopressin; Arterial Occlusive Diseases; Blood Pressure; Brain Ischemia; Carotid Arteries; Cerebral Cortex; Glyburide; Guanidines; Hypertension; Hypoglycemic Agents; Injections, Intravenous; Injections, Intraventricular; Ligation; Male; Pinacidil; Piperidines; Potassium Channels; Quinolones; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1996 |
Pharmacological studies of a novel prolyl endopeptidase inhibitor, JTP-4819, in rats with middle cerebral artery occlusion.
Topics: Animals; Arginine Vasopressin; Arterial Occlusive Diseases; Avoidance Learning; Brain Ischemia; Cerebral Arteries; Cerebral Cortex; Hippocampus; Learning; Male; Maze Learning; Motor Activity; Protease Inhibitors; Pyrrolidines; Rats; Rats, Sprague-Dawley; Substance P; Thyrotropin-Releasing Hormone | 1996 |